Improved subjective tolerability of interferon by combination with prednisolone.
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D004359:Drug Therapy, Combination; D004361:Drug Tolerance; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use*
D007370:Interferon Type I; D011239:Prednisolone